CAS: 1352914-52-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CR-1-31-B REF: 4Z-K-031114CAS: 1352914-52-3 | - - - | A consultar | Jue 03 Abr 25 |
 | Cr-1-31-B REF: 3D-CEC91452CAS: 1352914-52-3 | Min. 95% | A consultar | Jue 08 May 25 |
 | CR-1-31-B REF: TM-T38753CAS: 1352914-52-3 | - - - | 663,00 €~2.242,00 € | Jue 29 May 25 |
Ref: 4Z-K-031114
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 3 de Abril de 2025
Cr-1-31-B
CAS:1352914-52-3
Cr-1-31-B is a peptide inhibitor of the protein interactions. It has been shown to be …
Fórmula:
C28H29NO8
Pureza:
Min. 95%
Peso molecular:
507.5 g/mol
Ref: 3D-CEC91452
| 1mg | 531,00 € | ||
| 2mg | 860,00 € | ||
| 5mg | 1.548,00 € | ||
| 10mg | 2.500,00 € | ||
| 500µg | 388,00 € |
Entrega estimada en Estados Unidos, el Jueves 8 de Mayo de 2025
CR-1-31-B
CAS:1352914-52-3
CR-1-31-B, a synthetic rocaglate, inhibits eIF4A, hinders protein synthesis initiation, and induces apoptosis in cancer …
Fórmula:
C28H29NO8
Forma y color:
Solid
Peso molecular:
507.539
Ref: TM-T38753
| 5mg | 663,00 € | ||
| 10mg | 1.130,00 € | ||
| 25mg | 2.242,00 € |
Entrega estimada en Estados Unidos, el Jueves 29 de Mayo de 2025
